About
Technology
Issues
FAQ
Links
Official Page
Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.